News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,786 Results
Type
Article (40300)
Company Profile (256)
Press Release (669219)
Multimedia
Podcasts (68)
Webinars (15)
Section
Business (204417)
Career Advice (2015)
Deals (35470)
Drug Delivery (99)
Drug Development (81208)
Employer Resources (172)
FDA (16291)
Job Trends (14907)
News (345786)
Policy (32663)
Tag
Academia (2557)
Accelerated approval (14)
Adcomms (24)
Allergies (108)
Alliances (49572)
ALS (126)
Alzheimer's disease (1518)
Antibody-drug conjugate (ADC) (168)
Approvals (16342)
Artificial intelligence (353)
Autoimmune disease (39)
Automation (23)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (133)
Biotechnology (174)
Bladder cancer (111)
Brain cancer (39)
Breast cancer (411)
Cancer (3295)
Cardiovascular disease (269)
Career advice (1689)
Career pathing (32)
CAR-T (203)
CDC (37)
Cell therapy (545)
Cervical cancer (27)
Clinical research (67471)
Collaboration (1179)
Company closure (4)
Compensation (833)
Complete response letters (36)
COVID-19 (2658)
CRISPR (67)
C-suite (474)
Cystic fibrosis (120)
Data (3716)
Decentralized trials (2)
Denatured (22)
Depression (81)
Diabetes (390)
Diagnostics (6488)
Digital health (27)
Diversity (10)
Diversity, equity & inclusion (45)
Drug discovery (162)
Drug pricing (136)
Drug shortages (28)
Duchenne muscular dystrophy (170)
Earnings (88536)
Editorial (44)
Employer branding (21)
Employer resources (148)
Events (114630)
Executive appointments (889)
FDA (18428)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1046)
Gene editing (147)
Generative AI (25)
Gene therapy (429)
GLP-1 (839)
Government (4571)
Grass and pollen (5)
Guidances (331)
Healthcare (18851)
HIV (42)
Huntington's disease (32)
IgA nephropathy (47)
Immunology and inflammation (184)
Immuno-oncology (13)
Indications (45)
Infectious disease (2851)
Inflammatory bowel disease (162)
Inflation Reduction Act (10)
Influenza (77)
Intellectual property (161)
Interviews (314)
IPO (16604)
IRA (48)
Job creations (3639)
Job search strategy (1424)
Kidney cancer (13)
Labor market (64)
Layoffs (521)
Leadership (22)
Legal (7934)
Liver cancer (83)
Longevity (11)
Lung cancer (475)
Lymphoma (242)
Machine learning (22)
Management (58)
Manufacturing (507)
MASH (109)
Medical device (13558)
Medtech (13575)
Mergers & acquisitions (19670)
Metabolic disorders (951)
Multiple sclerosis (111)
NASH (16)
Neurodegenerative disease (154)
Neuropsychiatric disorders (37)
Neuroscience (2330)
NextGen: Class of 2025 (6517)
Non-profit (4492)
Now hiring (53)
Obesity (463)
Opinion (229)
Ovarian cancer (110)
Pain (138)
Pancreatic cancer (141)
Parkinson's disease (199)
Partnered (24)
Patents (365)
Patient recruitment (260)
Peanut (52)
People (58013)
Pharmaceutical (63)
Pharmacy benefit managers (21)
Phase I (20998)
Phase II (29720)
Phase III (22113)
Pipeline (2397)
Policy (230)
Postmarket research (2564)
Preclinical (8949)
Press Release (64)
Prostate cancer (163)
Psychedelics (39)
Radiopharmaceuticals (255)
Rare diseases (519)
Real estate (5927)
Recruiting (66)
Regulatory (23114)
Reports (51)
Research institute (2335)
Resumes & cover letters (350)
Rett syndrome (11)
RNA editing (11)
RSV (55)
Schizophrenia (108)
Series A (172)
Series B (130)
Service/supplier (11)
Sickle cell disease (68)
Special edition (20)
Spinal muscular atrophy (148)
Sponsored (34)
Startups (3595)
State (2)
Stomach cancer (14)
Supply chain (87)
Tariffs (72)
The Weekly (44)
Vaccines (861)
Venture capital (59)
Weight loss (291)
Women's health (51)
Worklife (17)
Date
Today (126)
Last 7 days (454)
Last 30 days (2241)
Last 365 days (30842)
2025 (21684)
2024 (35217)
2023 (40076)
2022 (51174)
2021 (55711)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (724)
Alabama (69)
Alaska (7)
Arizona (260)
Arkansas (13)
Asia (38459)
Australia (6272)
California (8549)
Canada (2645)
China (774)
Colorado (358)
Connecticut (366)
Delaware (226)
Europe (82779)
Florida (1275)
Georgia (287)
Hawaii (2)
Idaho (60)
Illinois (680)
India (39)
Indiana (404)
Iowa (17)
Japan (260)
Kansas (116)
Kentucky (31)
Louisiana (16)
Maine (65)
Maryland (1133)
Massachusetts (6255)
Michigan (266)
Minnesota (504)
Mississippi (4)
Missouri (101)
Montana (28)
Nebraska (25)
Nevada (98)
New Hampshire (68)
New Jersey (2334)
New Mexico (28)
New York (2320)
North Carolina (1194)
North Dakota (8)
Northern California (3878)
Ohio (261)
Oklahoma (17)
Oregon (35)
Pennsylvania (1805)
Puerto Rico (17)
Rhode Island (41)
South America (1099)
South Carolina (43)
South Dakota (1)
Southern California (3284)
Tennessee (138)
Texas (1318)
United States (31122)
Utah (253)
Virginia (210)
Washington D.C. (75)
Washington State (710)
West Virginia (4)
Wisconsin (72)
709,786 Results for "teneobio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Amgen Successfully Completes Acquisition Of Teneobio, Inc.
Amgen (NASDAQ: AMGN) today announced that it has successfully completed its previously announced acquisition of Teneobio, Inc. (Teneobio).
October 19, 2021
·
9 min read
Deals
Newly-Formed Ancora Biotech Will Continue Operations of Teneobio Spin-offs After Successful Acquisition of Teneobio by Amgen
Ancora Biotech announced, in connection with the closing of the acquisition of Teneobio, Inc., by Amgen Inc., that Teneobio’s former shareholders and their representatives will provide oversight of three previous affiliates of Teneobio, including TeneoTwo, Inc. (TNB-486, anti-CD19xCD3), TeneoFour, Inc. (anti-CD38 enzyme inhibitor TNB-738) and TeneoTen, Inc. (anti-HBVxCD3).
October 27, 2021
·
2 min read
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES ACQUISITION AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
September 11, 2025
·
4 min read
Press Releases
KBI Biopharma, Inc. Announces Collaboration with Infinimmune Inc. to Support Antibody Manufacturing
September 9, 2025
·
3 min read
Press Releases
MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS’
September 11, 2025
·
4 min read
Press Releases
genXtraits Inc. and Mendel Biotechnology, Inc. enter collaboration
August 21, 2025
·
3 min read
Press Releases
89bio, Inc. Announces Agreement to be Acquired by Roche
September 18, 2025
·
9 min read
Press Releases
Bionano Genomics, Inc. Announces Closing of $10 Million Public Offering
September 18, 2025
·
6 min read
Press Releases
Bionano Genomics, Inc. Announces Pricing of $10 Million Public Offering
September 17, 2025
·
7 min read
Press Releases
BioSig Technologies, Inc. Announces Corporate Rebrand to Streamex Corp.
September 11, 2025
·
3 min read
1 of 70,979
Next
